Is 3b Blackbio Dx a good stock to invest in?

3b Blackbio Dx can be analyzed on the following key metrics - TTM P/E: 29.04 Sector P/E: 17.63 Dividend Yield: 0.28% D/E ratio: -

3b Blackbio Dx Share Price

Sector: Chemical Manufacturing

Powered by

1427.00 +25.30 (1.80%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 1398.70

Today’s High 1435.00

52 Week Low 990.00

52 Week High 2350.00

Key Metrics

Market Cap (In Cr) 1217.79
Beta 0.9
Div. Yield (%) 0.28
P/B 4.56
TTM P/E 29.04
Sector P/E 17.63
D/E 0
Open Price 1425
Prev Close 1401.7

View All Metrics

3b Blackbio Dx Analysis

Price Analysis

1 Week

-3.07%
3 Months

-11.71%
6 Month

-28.83%
YTD

-27.85%
1 Year

24.6%

Risk Meter

69% Low risk
69% Moderate risk
69% Balanced Risk
69% High risk
69% Extreme risk

3b Blackbio Dx News

Premium

3B Blackbio DX Q1 Results Live : profit rise by 52.75% YOY

1 min read . 14 Aug 2024

View More News

3b Blackbio Dx Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
96.47

Selling/ General/ Admin Expenses Total
7.32

Depreciation/ Amortization
1.09

Other Operating Expenses Total
13.39

Total Operating Expense
47.45

Operating Income
49.02

Net Income Before Taxes
64

Net Income
47.65

Diluted Normalized EPS
55.66

Period
2024

Total Revenue
74.12

Selling/ General/ Admin Expenses Total
6.5

Depreciation/ Amortization
1.06

Other Operating Expenses Total
12.8

Total Operating Expense
42.2

Operating Income
31.92

Net Income Before Taxes
44.33

Net Income
32.1

Diluted Normalized EPS
37.46

Period
2023

Total Revenue
61.84

Selling/ General/ Admin Expenses Total
5.03

Depreciation/ Amortization
0.86

Other Operating Expenses Total
9.75

Total Operating Expense
33.55

Operating Income
28.28

Net Income Before Taxes
35.31

Net Income
25.94

Diluted Normalized EPS
30.28

Period
2022

Total Revenue
80.65

Selling/ General/ Admin Expenses Total
3.56

Depreciation/ Amortization
0.67

Other Operating Expenses Total
8.36

Total Operating Expense
44.22

Operating Income
36.43

Net Income Before Taxes
43.22

Net Income
32.2

Diluted Normalized EPS
42.98

Period
2021

Total Revenue
226.74

Selling/ General/ Admin Expenses Total
4.67

Depreciation/ Amortization
0.62

Other Operating Expenses Total
20.51

Total Operating Expense
77.37

Operating Income
149.37

Net Income Before Taxes
152.04

Net Income
113.87

Diluted Normalized EPS
152

Period
2020

Total Revenue
28.87

Selling/ General/ Admin Expenses Total
2.85

Depreciation/ Amortization
0.54

Other Operating Expenses Total
3.45

Total Operating Expense
20.09

Operating Income
8.79

Net Income Before Taxes
10.05

Net Income
7.69

Diluted Normalized EPS
10.26

Period
2019

Total Revenue
23.28

Selling/ General/ Admin Expenses Total
2.53

Depreciation/ Amortization
0.55

Other Operating Expenses Total
2.69

Total Operating Expense
16.6

Operating Income
6.67

Net Income Before Taxes
6.95

Net Income
5.24

Diluted Normalized EPS
8.2

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

3b Blackbio Dx Technical

Moving Average SMA

5 Day1416.9
10 Day1456.71
20 Day1545.5

50 Day1657.43
100 Day1725.93
300 Day1689.51

3b Blackbio Dx Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Amines & Plasticizers
245.4
-2.6
-1.05
359
185.35
1339.39

Heubach Colorants India
586.5
-1.5
-0.26
733.25
437.1
1353.75

3b Blackbio Dx
1427
25.3
1.8
2350
990
1217.79

Heranba Industriesord
304.5
-5.5
-1.77
561
205.2
1218.41

Fairchem Organics
938.25
-6.75
-0.71
1552
747.3
1219.69

3b Blackbio Dx Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

28-May-25
Audited Results & Dividend

13-Feb-25
Quarterly Results

13-Nov-24
Quarterly Results

12-Aug-24
Quarterly Results

29-May-24
Audited Results

09-Feb-24
Quarterly Results

10-Nov-23
Quarterly Results

29-Aug-23
Amalgamation

11-Aug-23
Quarterly Results

29-May-23
Audited Results

Meeting Date
Announced on
Purpose

24-Sept-24
04-Sept-24
AGM

22-Sept-23
30-Aug-23
AGM

Announced on
Record Date
Ex-Dividend
Dividend Value

28-May-25
-
-
4

30-May-24
-
17-Sept-24
3

30-Aug-23
-
15-Sept-23
2.5

27-May-22
-
14-Sept-22
2.5

23-Jun-21
-
14-Sept-21
1

24-Jun-21
-
14-Sept-21
8

View All

Company Profile

ABOUT 3b Blackbio Dx

Industry Chemical Manufacturing
ISIN INE994E01018
BSE Code 532067

3B Blackbio DX Limited is an India-based company, which is engaged in the field of polymerase chain reaction (PCR)-based Molecular Diagnostic Kits. Its segments include Agrochemicals and Diagnostic kits. The diagnostics division of the Company is engaged in Design, Development Manufacturing and Commercialization of qPCR tests, Rapid tests, Next Gen Sequencing (NGS)-based Molecular Diagnostic Kits and Extraction Kits for reliable testing on patient samples. Its products include Oncology and Hematology, Antimicrobial Resistance, Infectious Diseases, Human Genetics, Extraction, and Rapid Antigen Kits. The PCR-based Molecular Diagnostic Kits are commercialized with TRUPCR brand to renowned diagnostics labs across the country. The Company also has a Lateral Flow Assays Vertical and a NGS Assay development division. The lateral flow assays are commercialized under the brand name TRURAPID and the NGS assays are commercialized under the brand name TRUNGS.

MANAGEMENT

Dhirendra Dubey Chairman of the Board, Managing Director
Navneet Kaur Compliance Officer, Company Secretary
Nikhil Dubey Whole Time Director

3B BLACKBIO DX SUMMARY

3b Blackbio Dx is trading 1.80% upper at Rs 1427.00 as compared to its last closing price. 3b Blackbio Dx has been trading in the price range of 1435.00 & 1398.70. 3b Blackbio Dx has given -27.85% in this year & -3.07% in the last 5 days.

3b Blackbio Dx has TTM P/E ratio 29.04 as compared to the sector P/E of 17.63.

The company posted a net profit of 8.4 Crores in its last quarter.

Listed peers of 3b Blackbio Dx include Amines & Plasticizers (-1.05%), Heubach Colorants India (-0.26%), 3b Blackbio Dx (1.8%) etc.

3b Blackbio Dx has a 41.28% promoter holding & 58.72% public holding.

FAQs about 3b Blackbio Dx

3b Blackbio Dx is trading at 1427.00 as on 27 Jun, 2025 3:29:20 PM. This is 1.80% upper as compared to its previous closing price of 1401.7

The market capitalization of 3b Blackbio Dx is 1217.79 Cr as on 27 Jun, 2025 3:29:20 PM.

The 52 wk high for 3b Blackbio Dx is 2350.00 whereas the 52 wk low is 990.00

3b Blackbio Dx can be analyzed on the following key metrics -

TTM P/E: 29.04
Sector P/E: 17.63
Dividend Yield: 0.28%
D/E ratio: -

3b Blackbio Dx reported a net profit of 47.65 Cr in 2025.

3b Blackbio Dx Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

3b Blackbio Dx Share Price

Price Range

Key Metrics

3b Blackbio Dx Analysis

3b Blackbio Dx News

3B Blackbio DX Q1 Results Live : profit rise by 52.75% YOY

3b Blackbio Dx Financials

Forecast

Forecast

Forecast

3b Blackbio Dx Technical

3b Blackbio Dx Peers

3b Blackbio Dx Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT 3b Blackbio Dx

MANAGEMENT

3B BLACKBIO DX SUMMARY

FAQs about 3b Blackbio Dx

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue